7 months ago
SRPT
AnalystsGil BlumGil Blum's Stock Forecasts
AnalystsGil Blum
Sectors:
Industries:
Analyst Ranking
Bottom 3%
#4829 out of 4929 analysts
Average Return
-2.47%
Win Rate
38%157 out of 412
Risk vs Reward
Poor
Good
Gil Blum's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mereo Biopharma Group PLCMREO | +364.14% | $0.71 | $3.30 | 2023-03-29 - 2024-03-28 | Buy |
Taysha Gene Therapies IncTSHA | +341.54% | $0.65 | $2.87 | 2023-03-28 - 2024-03-28 | Buy |
Nurix Therapeutics IncNRIX | +270.96% | $6.37 | $23.63 | 2023-10-12 - 2024-10-11 | Buy |
Cti Biopharma CorpCTIC | +267.07% | $1.64 | $6.02 | 2021-11-30 - 2022-11-30 | Buy |
Taysha Gene Therapies IncTSHA | +248.73% | $0.67 | $2.34 | 2023-05-11 - 2024-05-10 | Buy |
Gil Blum Analyst Color
Get additional color on Gil Blum's coverage of popular stocks
a year ago
AUTL
a year ago
AUTL
Gil Blum's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Taysha Gene Therapies IncTSHA | 29 | Buy | $8.00 | +226.53% | Reiterates | 6 days ago |
Celcuity IncCELC | 17 | Buy | $29.00 | +110.30% | Reiterates | 7 days ago |
I MabIMAB | 14 | Buy | $5.00 | +132.56% | Maintains | 10 days ago |
Crispr Therapeutics AgCRSP | 23 | Buy | $81.00 | +55.26% | Reiterates | 11 days ago |
Sarepta Therapeutics IncSRPT | 31 | Buy | $50.00 | +174.12% | Maintains | 21 days ago |
Autolus Therapeutics PLCAUTL | 28 | Buy | $10.00 | +321.94% | Reiterates | 25 days ago |
Rocket Pharmaceuticals IncRCKT | 21 | Hold | $42.00 | +1,348.28% | Downgrades | a month ago |
Nkarta IncNKTX | 16 | Buy | $10.00 | +471.43% | Maintains | 2 months ago |
Artiva Biotherapeutics IncARTV | 6 | Buy | $18.00 | +1,018.01% | Maintains | 2 months ago |
Absci CorpABSI | 4 | Buy | $9.00 | +224.91% | Reiterates | 2 months ago |
Mereo Biopharma Group PLCMREO | 18 | Buy | $7.00 | +143.90% | Reiterates | 2 months ago |
Cartesian Therapeutics IncRNAC | 23 | Buy | $40.00 | +256.82% | Maintains | 2 months ago |
Generation Bio CoGBIO | 17 | Buy | $8.00 | +2,232.36% | Reiterates | 2 months ago |
Recursion Pharmaceuticals IncRXRX | 23 | Buy | $8.00 | +51.80% | Maintains | 2 months ago |
Nurix Therapeutics IncNRIX | 24 | Buy | $27.00 | +112.10% | Reiterates | 2 months ago |
Immunocore Holdings PLCIMCR | 14 | Buy | $71.00 | +115.02% | Reiterates | 3 months ago |
Tscan Therapeutics IncTCRX | 7 | Buy | $9.00 | +496.03% | Reiterates | 3 months ago |
Geron CorpGERN | 22 | Buy | $5.00 | +249.65% | Reiterates | 4 months ago |
Arcellx IncACLX | 22 | Buy | $105.00 | +56.34% | Reiterates | 7 months ago |
Shattuck Labs IncSTTK | 13 | Hold | $8.00 | +860.38% | Downgrades | 9 months ago |
Nextcure IncNXTC | 9 | Buy | $4.00 | +817.43% | Reiterates | a year ago |
G1 Therapeutics IncGTHX | 17 | Buy | $6.00 | N/A | Maintains | a year ago |
Gamida Cell LtdGMDAQ | 8 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Cti Biopharma CorpCTIC | 5 | Buy | $9.00 | N/A | Reiterates | 2 years ago |
Tectonic Therapeutic IncTECX | 4 | Buy | $72.00 | N/A | Reiterates | 2 years ago |
Fate Therapeutics IncFATE | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $225.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.